MAPK
-
Tomatidine
Catalog No. A16233 -
CC-90003
Catalog No. A16837 -
MK-8353 (SCH900353)
Catalog No. A16838 ERK 抑制剂MK-8353 (SCH900353)是一种口服生物利用型,选择性和有效的ERK抑制剂,在体外抑制激活的ERK1和ERK2,IC50值分别为23.0 nM和8.8 nM(IMAP激酶测定),以及未激活的ERK2,具有IC50值 0.5 nM(MEK1-ERK2耦合测定)。 了解更多 -
-
最新产品
AG-126
Catalog No. A17146 -
-
Doramapimod (BIRB-796)
Catalog No. A10148 p38 MAPK 抑制剂Doramapimod(BIRB 796)是p38 MAPK的小分子抑制剂,在调节促炎细胞因子的产生中起关键作用。 了解更多 -
PH-797804
Catalog No. A11078 -
Skepinone-L
Catalog No. A11321 -
SB-242235
Catalog No. A13678 -
BMS-582949
Catalog No. A13563 -
Pexmetinib (ARRY-614)
Catalog No. A10895 p38 MAPK 抑制剂Pexmetinib (ARRY-614)是通过双重抑制p38促分裂原活化蛋白激酶(MAPK)和Tie2/Tek受体酪氨酸激酶,其在HEK-293细胞中的IC50分别为4 nM/18 nM。Pexmetinib是一种有效的细胞因子合成抑制剂。 了解更多 -
AMG 548
Catalog No. A10970 -
SKF 86002 Dihydrochloride
Catalog No. A11101 p38 MAPK 抑制剂SKF 86002 Dihydrochloride是p38 MAP激酶的抑制剂(IC50 = 0.1-1 uM)。有效抑制人单核细胞中LPS诱导的IL-1和TNF-α的产生(IC50 = 1 uM)。 了解更多 -
AL 8697
Catalog No. A16015 -
SX 011
Catalog No. A16035 -
EO 1428
Catalog No. A16037 -
SB 706504
Catalog No. A16055 -
DBM 1285 dihydrochloride
Catalog No. A16058 -
LY2228820 (Ralimetinib)
Catalog No. A10545 -
VX-745
Catalog No. A10983 -
Asiatic acid
Catalog No. A10092 Anti-inflammatory agentAsiatic acid常用于伤口愈合。亚洲酸具有抗氧化,抗炎和神经保护的特性。积雪草酸衍生物的合成可用作抗癌剂;糖原磷酸化酶抑制剂;保肝剂。 了解更多 -
Asiaticoside
Catalog No. A12021 Asiaticoside是植物积雪草的活性化学成分。积雪草苷用于研究伤口和烧伤的潜在治疗方法。 了解更多 -
Talmapimod (SCIO-469)
Catalog No. A12770 -
Losmapimod (GW856553X)
Catalog No. A12526 p38 MAPK 抑制剂Losmapimod,也称为GW856553或GW856553X,是葛兰素史克(GlaxoSmithKline)开发的药物,可作为酶家族的选择性抑制剂,称为p38促分裂原活化蛋白激酶,其作用于p38α和p38β的pKi分别为8.1和7.6 。 了解更多 -
Pamapimod (R-1503)
Catalog No. A13551 -
CMPD-1
Catalog No. A16040 -
TA-02
Catalog No. A13644 -
FR 167653 free base
Catalog No. A21110 p38 MAPK inhibitorFR 167653 free base, an orally active and selective p38 MAPK inhibitor, is a potent suppressor of TNF-α and IL-1β production via specific inhibition of p38 MAPK activity. 了解更多 -
SB 203580 hydrochloride
Catalog No. A21526 p38 MAPK inhibitorSB 203580 hydrochloride (RWJ 64809 hydrochloride) is a widely used p38 MAPK inhibitor. 了解更多 -
MW-150 hydrochloride
Catalog No. A21854 p38α MAPK inhibitorMW-150 hydrochloride (MW01-18-150SRM hydrochloride) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
MW-150 dihydrochloride dihydrate
Catalog No. A21860 p38α MAPK inhibitorMW-150 dihydrochloride dihydrate (MW01-18-150SRM dihydrochloride dihydrate) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. 了解更多 -
BMS-582949 hydrochloride
Catalog No. A21914 p38α MAPK inhibitorBMS-582949 hydrochloride is an orally active and highly selective p38α MAPK inhibitor, with an IC50 of 13 nM. 了解更多 -
Ralimetinib
Catalog No. A21942 p38 MAPK α/β inhibitorRalimetinib (LY2228820) is a potent and selective, ATP-competitive inhibitor of p38 MAPK α/β, with IC50s of 5.3 and 3.2 nM, respectively. 了解更多 -
p38-α MAPK-IN-1
Catalog No. A21036 MAPK14 inhibitorp38-α MAPK-IN-1 is an inhibitor of MAPK14 (p38-α), with IC50 of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay. 了解更多 -
MAPK13-IN-1
Catalog No. A21038 MAPK13 (p38??) inhibitorMPAK13-IN-1 is a MAPK13 (p38δ) inhibitor, with an IC50 of 620 nM. 了解更多